NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Shari Redstone faces a dilemma over whether to protect ’60 Minutes’ from a nuisance Trump lawsuit or keep Paramount on track for its Skydance mergerRead More